VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KMPR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KMPRKemper Corporation
$27.31$1.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKMPRFinancials

Kemper Corporation (KMPR) Financials

30Y historyFree accessUpdated daily

Underwriting profitability remains under pressure as the combined ratio deteriorated to 100.7% in 2026Q1, reflecting a failure to outpace rising claim costs.

KMPR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue4.71B4.8B4.63B4.95B5.45B5.61B5.18B5.02B3.69B2.67B2.52B2.34B2.2B2.43B2.46B2.5B2.64B2.93B2.74B2.9B2.86B2.83B2.82B2.67B2.3B2.53B1.95B1.81B2.09B1.56B1.57B
Revenue Growth %0.58%3.62%-6.32%-9.27%-2.92%8.42%3.16%36.13%38.17%5.83%7.74%6.56%-9.47%-1.45%-1.31%-5.58%-9.92%6.97%-5.54%1.6%0.99%0.36%5.62%16.14%-9.3%29.73%7.7%-13.05%34.12%-1.17%5.44%
Medical Costs & Claims4.05B3.38B4.04B3.82B5.66B5.26B4.02B3.83B2.92B2.23B2.16B1.83B1.59B1.7B1.94B2B1.65B1.74B1.77B2.28B2.22B2.29B2.49B2.58B2.16B1.84B1.65B1.46B1.29B1.26B1.29B
Medical Cost Ratio %85.95%70.32%87.28%77.25%103.88%93.68%77.58%76.3%79.2%83.54%85.82%78.07%72.2%70.2%78.74%80.22%62.33%59.3%64.37%78.47%77.72%80.77%88.4%96.85%94.12%72.69%84.43%80.65%61.82%81.05%81.71%
Gross Profit661.7M1.43B589.4M1.13B-211.3M354.8M1.16B1.19B766.9M439.2M357.5M513.4M610.7M723.1M523.5M493.6M995.3M1.19B977M624.9M636.5M544M326.9M84.2M135.2M691.9M304.1M350.9M796.4M294.8M287.8M
Gross Margin %14.05%29.68%12.72%22.75%-3.88%6.32%22.42%23.7%20.8%16.46%14.18%21.93%27.8%29.8%21.26%19.78%37.67%40.7%35.63%21.53%22.28%19.23%11.6%3.15%5.88%27.31%15.57%19.35%38.18%18.95%18.29%
Gross Profit Growth %-141.77%-47.62%632.56%-159.55%-69.44%-2.45%55.17%74.61%22.85%-30.37%-15.93%-15.54%38.13%6.06%-50.41%-16.63%22.2%56.34%-1.82%17%66.41%288.24%-37.72%-80.46%127.52%-13.34%-55.94%170.15%2.43%-80.72%
Operating Expenses628.7M1.26B200.9M1.47B159.7M604.2M650.8M528.4M567.8M278.1M354M413.1M450.5M408.7M401.1M425.3M758.6M964.3M1.07B398.1M266.5M232.4M213.1M199.9M159.8M149.4M-1.5B113.9M109.3M-1.13B-1.17B
OpEx / Revenue %13.35%26.34%4.34%29.77%2.93%10.76%12.57%10.53%15.4%10.42%14.04%17.65%20.51%16.84%16.29%17.05%28.71%32.87%38.91%13.71%9.33%8.21%7.56%7.49%6.95%5.9%-76.65%6.28%5.24%-72.7%-74.4%
Depreciation & Amortization-900K74.3M53.7M58.6M70.9M99.8M55M62.5M171.9M18.2M19.5M28.9M23.2M25.7M23.3M22.3M25.5M344.3M353.5M357.4M364.8M11.6M12.6M11.4M245.6M189.6M12.1M163.1M149.3M167.4M170.1M
Combined Ratio %99.3%96.65%91.61%107.02%106.81%104.44%90.15%86.82%94.6%93.96%99.86%95.72%92.71%87.04%95.03%97.26%91.04%92.17%103.28%92.19%87.05%88.99%95.96%104.33%101.07%78.59%7.78%86.93%67.06%8.35%7.31%
Operating Income33M160.7M388.5M-347.1M-371M-249.4M510.1M661.6M199.1M161.1M3.5M100.3M160.2M314.4M122.4M68.3M236.7M229.6M-90M226.8M370M311.6M113.8M-115.7M-24.6M542.5M1.8B237M687.1M1.43B1.46B
Operating Margin %0.7%3.35%8.39%-7.02%-6.81%-4.44%9.85%13.18%5.4%6.04%0.14%4.28%7.29%12.96%4.97%2.74%8.96%7.83%-3.28%7.81%12.95%11.01%4.04%-4.33%-1.07%21.41%92.22%13.07%32.94%91.65%92.69%
Operating Income Growth %--58.64%211.93%6.44%-48.76%-148.89%-22.9%232.3%23.59%4502.86%-96.51%-37.39%-49.05%156.86%79.21%-71.14%3.09%355.11%-139.68%-38.7%18.74%173.81%198.36%-370.33%-104.53%-69.88%660.04%-65.51%-51.8%-2.27%5.56%
EBITDA32.1M235M442.2M-288.5M-300.1M-149.6M565.1M724.1M371M179.3M23M129.2M183.4M340.1M145.7M90.6M262.2M573.9M263.5M584.2M734.8M323.2M126.4M-104.3M221M732.1M1.81B400.1M836.4M1.59B1.63B
EBITDA Margin %0.68%4.9%9.55%-5.83%-5.51%-2.66%10.91%14.42%10.06%6.72%0.91%5.52%8.35%14.02%5.92%3.63%9.92%19.56%9.61%20.12%25.72%11.42%4.48%-3.91%9.62%28.89%92.84%22.06%40.1%102.42%103.49%
Interest Expense36.4M38.5M56.9M56.1M54.7M43.6M36M42.5M43.4M34.9M44.4M46.5M46.9M38.1M37.6M36.9M68.3M241.6M321.3M398.1M62.5M64M57.4M45.3M26.9M22.2M151.9M113.9M109.3M129.8M115.1M
Non-Operating Income2.1M-38.5M-56.9M-56.1M-54.7M-43.7M-36M-42.5M-43.4M-34.9M-44.4M-46.5M-46.9M-38.1M-37.6M-36.9M-68.3M-241.6M-321.3M-398.1M-62.5M-64M-279.1M-319.9M-26.9M-22.2M1.65B-113.9M-109.3M1.3B1.34B
Pretax Income33M160.7M388.5M-347.1M-371M-249.3M510.1M661.6M199.1M161.1M3.5M100.3M160.2M314.4M122.4M68.3M236.7M229.6M-90M226.8M370M311.6M335.5M158.9M-24.6M542.5M145.4M237M687.1M165M172.7M
Pretax Margin %0.7%3.35%8.39%-7.02%-6.81%-4.44%9.85%13.18%5.4%6.04%0.14%4.28%7.29%12.96%4.97%2.74%8.96%7.83%-3.28%7.81%12.95%11.01%11.9%5.95%-1.07%21.41%7.44%13.07%32.94%10.61%10.97%
Income Tax1.8M28.1M76M-74.8M-84.4M-125.6M100.2M130.5M10.7M41.2M-9.2M20.1M47.6M99.9M30.6M6.6M67.5M66.4M-46.2M49.9M115M80.2M98.9M34.1M-18.3M190.3M54.4M77.9M238.6M47.1M40.2M
Effective Tax Rate %5.45%17.49%19.56%21.55%22.75%50.38%19.64%19.72%5.37%25.57%-262.86%20.04%29.71%31.77%25%9.66%28.52%28.92%51.33%22%31.08%25.74%29.48%21.46%74.39%35.08%37.41%32.87%34.73%28.55%23.28%
Net Income41.9M143.3M317.8M-272.1M-286.6M-123.7M409.9M531.1M190.1M120.9M16.8M85.7M114.5M217.7M103.4M74.5M184.6M164.7M-29.6M205.4M283.1M255.5M240.2M123.6M-8.2M380.9M91M201M510.8M117.9M132.5M
Net Margin %0.89%2.99%6.86%-5.5%-5.26%-2.2%7.92%10.58%5.15%4.53%0.67%3.66%5.21%8.97%4.2%2.99%6.99%5.61%-1.08%7.08%9.91%9.03%8.52%4.63%-0.36%15.03%4.66%11.08%24.49%7.58%8.42%
Net Income Growth %-87.9%-54.91%216.8%5.06%-131.69%-130.18%-22.82%179.38%57.24%619.64%-80.4%-25.15%-47.4%110.54%38.79%-59.64%12.08%656.42%-114.41%-27.45%10.8%6.37%94.34%1607.32%-102.15%318.57%-54.73%-60.65%333.25%-11.02%-12.02%
EPS (Diluted)0.712.294.91-4.25-4.72-1.886.147.963.242.330.331.652.123.801.741.382.982.64-0.473.124.153.673.481.82-0.125.601.322.746.511.561.74
EPS Growth %-89.44%-53.36%215.53%9.96%-151.06%-130.62%-22.86%145.68%39.06%606.06%-80%-22.17%-44.21%118.39%26.09%-53.69%12.88%661.7%-115.06%-24.82%13.08%5.46%91.21%1616.67%-102.14%324.24%-51.82%-57.91%317.31%-10.34%-5.95%
EPS (Basic)-2.314.95-4.25-4.72-1.886.248.043.272.340.331.652.123.811.751.382.982.64-0.473.134.173.703.511.83-0.125.641.322.766.551.581.76
Diluted Shares Outstanding58.8M62.61M64.78M64.03M63.83M64.26M66.73M66.55M58.75M51.58M51.21M51.68M53.87M56.98M59.43M60.26M61.77M62.16M62.68M65.83M68.22M69.62M69.02M67.91M68.33M68.02M68.94M73.36M78.46M75.58M76.15M

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetStrained
Cash FlowDeteriorating
Top Statement Risk

Underwriting margin volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Top Line Contraction Amid Restructuring

As indicated by the most recent quarterly filings, Kemper's revenue growth has trended into negative territory, with a 6.8% decline in 2026Q1, reflecting the strategic exit from the Preferred P&C segment and ongoing challenges in maintaining premium volume within the core non-standard automobile insurance market.

The consistent year-over-year revenue contraction suggests that the company is struggling to offset the loss of premiums from its discontinued business lines. Investors should monitor whether the remaining specialty portfolio can achieve sufficient scale to stabilize the top line or if further shrinkage is required to reach a sustainable underwriting base.

Underwriting Profitability Under Persistent Pressure

Based on reported financial data, the combined ratio has deteriorated to 100.7% in 2026Q1, signaling that the company is currently failing to generate an underwriting profit as claim costs continue to outpace the pricing adjustments implemented across its specialty property and casualty insurance segments.

The persistent breach of the 100% combined ratio threshold implies that Kemper is currently reliant on non-underwriting sources to cover its operational costs. This trend warrants further investigation into whether the company's rate filing strategy in key states like California is sufficient to combat the ongoing inflationary pressures on loss severity.

Operational Volatility During Strategic Transition

According to the historical income statement data, the company experienced a significant inflection point in 2025Q3, where the loss ratio spiked to 100.0%, marking a period of extreme underwriting stress that has since forced a re-evaluation of the firm's core specialty property and casualty risk appetite.

This period of elevated loss activity appears to have been a catalyst for the subsequent strategic shift away from preferred lines. The volatility observed during this transition suggests that the company's earnings profile remains highly sensitive to sudden shifts in claim frequency and the adequacy of its existing loss reserves.

Reserve Adequacy and Earnings Quality Concerns

As reported in recent financial statements, the fluctuation in quarterly net income, which swung from a $99.7M profit in 2025Q1 to a $1.7M loss in 2026Q1, suggests that the company's earnings quality may be masked by significant volatility in loss development and potential reserve adjustments.

The sharp divergence between operating income and net income in several periods warrants further investigation into whether prior-year reserve releases are being used to artificially smooth earnings. Analysts should remain cautious regarding the sustainability of the company's bottom line until the combined ratio demonstrates a consistent return to sub-100% levels.

KMPR — Frequently Asked Questions

Quick answers to the most common questions about buying KMPR stock.

What was Kemper Corporation's (KMPR) revenue in 2025?

For fiscal year 2025, Kemper Corporation (KMPR) reported total revenue of $4.80B. This represents a 205.0% increase compared to $1.57B in 1996.

Is Kemper Corporation (KMPR) profitable?

Kemper Corporation (KMPR) is profitable, generating $143.3M in net income for the fiscal year ending 2025 with a net profit margin of 3.0%.

What is Kemper Corporation's operating profit margin?

Kemper Corporation (KMPR) reported an operating income of $160.7M, resulting in an operating profit margin of 3.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Kemper Corporation's gross profit and gross margin?

Kemper Corporation (KMPR) generated $1.43B in gross profit for the year, representing a gross profit margin of 29.7%. This demonstrates the company's core pricing power and production efficiency.